Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$17,721,579
+$3,327,179 QoQ
Shares Held
14,775
-5.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.37%
of 13F equity value
Holder Rank
#948
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETARY MANAGEMENT GROUP INC holds $39,611,391 across 9 Drug Manufacturers - General names. LLY ranks #1 (44.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
14,775 | $17,721,579 | |
| 2 | ABBV |
AbbVie Inc.
|
35,105 | $8,833,822 | |
| 3 | AMGN |
Amgen Inc
|
13,171 | $4,769,482 | |
| 4 | JNJ |
Johnson & Johnson
|
17,045 | $4,328,918 | |
| 5 | MRK |
Merck & Co., Inc.
|
15,685 | $2,015,522 | |
| 6 | PFE |
Pfizer Inc
|
38,004 | $915,136 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,850 | $798,037 | |
| 8 | NVS |
Novartis AG
|
1,259 | $197,310 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,721,579 | 14,775 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $14,394,400 | 15,650 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $17,146,520 | 15,955 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $12,478,865 | 16,355 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $12,690,748 | 16,280 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,532,535 | 16,385 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,714,840 | 16,470 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,290,212 | 16,130 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $14,762,220 | 16,305 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $13,050,279 | 16,775 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,947,529 | 17,065 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,265,492 | 17,250 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,136,803 | 17,350 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,360,138 | 18,520 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,797,307 | 18,580 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,284,307 | 19,435 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,873,676 | 21,200 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,135,477 | 21,425 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,951,159 | 21,545 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,553,995 | 19,710 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,420,555 | 19,260 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,677,551 | 19,685 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,239,195 | 19,185 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,839,763 | 19,185 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,401,132 | 14,625 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,118,948 | 15,275 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||